Claude Vezeau
Chief Executive Officer at Bellus Health (Innodia), Inc.
Claude Vezeau active positions
| Companies | Position | Start | End |
|---|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Chief Executive Officer | 2001-12-31 | - |
| Founder | 2001-12-31 | - | |
| President | 2001-12-31 | - |
Career history of Claude Vezeau
Former positions of Claude Vezeau
| Companies | Position | Start | End |
|---|---|---|---|
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | President | - | - |
Training of Claude Vezeau
| University of Minnesota | Doctorate Degree |
Statistics
International
| Canada | 3 |
| United States | 2 |
Operational
| President | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
- Stock Market
- Insiders
- Claude Vezeau
- Experience
